Third-look endoscopy prevents delayed bleeding after endoscopic submucosal dissection under antithrombotic therapy

Table 6 Postoperative delayed bleeding rate by each drug in third-look endoscopy (n = 114) and control (n = 132) group

	Overall		E-PDB		L-PDB
	TLE	Control	TLE	Control	TLE	Control
Aspirin, % (n)	6.0 (3/50)	3.4 (2/59)	2.0 (1/50)	3.4 (2/59)	4.0 (2/50)	0 (0/59)
Thienopyridine, % (n)	8.3 (1/12)	9.1 (1/11)	0 (0/12)	0 (0/11)	8.3 (1/12)	9.1 (1/11)
Cilostazol, % (n)	0 (0/6)	0 (0/14)	0 (0/6)	0 (0/14)	0 (0/6)	0 (0/14)
Warfarin, % (n)	0 (0/3)	0 (0/1)	0 (0/3)	0 (0/1)	0 (0/3)	0 (0/1)
DOAC, % (n)	13.0 (3/23)	23.1 (3/13)	4.3 (1/23)	0 (0/13)	8.7 (2/23)	23.1 (3/13)
Multiple antithrombotic agents, % (n)	10.0 (2/20)	32.4 (11/34)	5.0(1/20)	2.9 (1/34)	5.0 (1/20)	29.4 (10/34)

TLE: Third-look endoscopy; PDB: Postoperative delayed bleeding; DOAC: Direct oral anticoagulants.